Faramarzi S, Bassan A, Cross K, Yang X, Myatt G, Volpe D
Front Pharmacol. 2025; 15:1451164.
PMID: 40012840
PMC: 11860084.
DOI: 10.3389/fphar.2024.1451164.
Han Y, Kim H, Kim H
Arch Toxicol. 2024; 99(2):775-785.
PMID: 39661166
DOI: 10.1007/s00204-024-03924-x.
Mou Z, Volarath P, Racz R, Cross K, Girireddy M, Chakravarti S
Chem Res Toxicol. 2024; 37(12):1924-1933.
PMID: 39535830
PMC: 11653395.
DOI: 10.1021/acs.chemrestox.4c00186.
Steen E, Vugts D, Windhorst A
Front Nucl Med. 2024; 2:853475.
PMID: 39354992
PMC: 11440968.
DOI: 10.3389/fnume.2022.853475.
Aljallal M, Chaudhry Q, Price N
Sci Rep. 2024; 14(1):18330.
PMID: 39112641
PMC: 11306771.
DOI: 10.1038/s41598-024-69157-1.
A novel in vitro high-content imaging assay for the prediction of drug-induced lung toxicity.
Fitzpatrick P, Johansson J, Maglennon G, Wallace I, Hendrickx R, Stamou M
Arch Toxicol. 2024; 98(9):2985-2998.
PMID: 38806719
PMC: 11324770.
DOI: 10.1007/s00204-024-03800-8.
Mind your prevalence!.
Guesne S, Hanser T, Werner S, Boobier S, Scott S
J Cheminform. 2024; 16(1):43.
PMID: 38622648
PMC: 11017531.
DOI: 10.1186/s13321-024-00837-w.
Application of an Antioxidant Response Element-Nuclear Factor Erythroid 2 Luciferase Assay for Assessing the Skin Sensitization Potential of Agrochemicals.
Yang J, Park S, Shin J, Lim J, Yang S, Gil G
Toxics. 2023; 11(12).
PMID: 38133374
PMC: 10747178.
DOI: 10.3390/toxics11120973.
Enhancing developmental and reproductive toxicity knowledge: A new AOP stemming from glutathione depletion.
Myden A, Stalford S, Fowkes A, White E, Hirose A, Yamada T
Curr Res Toxicol. 2023; 5:100124.
PMID: 37808440
PMC: 10556594.
DOI: 10.1016/j.crtox.2023.100124.
Development of QSAR models to predict blood-brain barrier permeability.
Faramarzi S, Kim M, Volpe D, Cross K, Chakravarti S, Stavitskaya L
Front Pharmacol. 2022; 13:1040838.
PMID: 36339562
PMC: 9633177.
DOI: 10.3389/fphar.2022.1040838.
A scheme to evaluate structural alerts to predict toxicity - Assessing confidence by characterising uncertainties.
Cronin M, Bauer F, Bonnell M, Campos B, Ebbrell D, Firman J
Regul Toxicol Pharmacol. 2022; 135:105249.
PMID: 36041585
PMC: 9585125.
DOI: 10.1016/j.yrtph.2022.105249.
Development of a 96-Well Electrophilic Allergen Screening Assay for Skin Sensitization Using a Measurement Science Approach.
Petersen E, Uhl R, Toman B, Elliott J, Strickland J, Truax J
Toxics. 2022; 10(5).
PMID: 35622670
PMC: 9147637.
DOI: 10.3390/toxics10050257.
Quantitative Structure-Activity Relationship Modeling of the Amplex Ultrared Assay to Predict Thyroperoxidase Inhibitory Activity.
Gadaleta D, dAlessandro L, Marzo M, Benfenati E, Roncaglioni A
Front Pharmacol. 2021; 12:713037.
PMID: 34456728
PMC: 8387701.
DOI: 10.3389/fphar.2021.713037.
SAR and QSAR modeling of a large collection of LD rat acute oral toxicity data.
Gadaleta D, Vukovic K, Toma C, Lavado G, Karmaus A, Mansouri K
J Cheminform. 2021; 11(1):58.
PMID: 33430989
PMC: 6717335.
DOI: 10.1186/s13321-019-0383-2.
Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh.
Kolle S, Landsiedel R
Handb Exp Pharmacol. 2020; 265:3-27.
PMID: 33136188
DOI: 10.1007/164_2020_368.
Predicting PBT and CMR properties of substances of very high concern (SVHCs) using QSAR models, and application for K-REACH.
Moon J, Lee B, Ra J, Kim K
Toxicol Rep. 2020; 7:995-1000.
PMID: 32874922
PMC: 7451722.
DOI: 10.1016/j.toxrep.2020.08.014.
A non-conformational QSAR study for plant-derived larvicides against Zika Aedes aegypti L. vector.
Saavedra L, Romanelli G, Duchowicz P
Environ Sci Pollut Res Int. 2019; 27(6):6205-6214.
PMID: 31865579
DOI: 10.1007/s11356-019-06630-9.
Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.
Landry C, Kim M, Kruhlak N, Cross K, Saiakhov R, Chakravarti S
Regul Toxicol Pharmacol. 2019; 109:104488.
PMID: 31586682
PMC: 6919322.
DOI: 10.1016/j.yrtph.2019.104488.
Linear Regression QSAR Models for Polo-Like Kinase-1 Inhibitors.
Duchowicz P
Cells. 2018; 7(2).
PMID: 29443884
PMC: 5850101.
DOI: 10.3390/cells7020013.
A Novel Strategy to Predict Carcinogenicity of Antiparasitics Based on a Combination of DNA Lesions and Bacterial Mutagenicity Tests.
Liu Q, Lei Z, Zhu F, Ihsan A, Wang X, Yuan Z
Front Public Health. 2017; 5:288.
PMID: 29170735
PMC: 5684118.
DOI: 10.3389/fpubh.2017.00288.
